v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 15,803 $ 67,311
General and administrative 158,971 201,455
Total operating expenses 174,774 268,766
Loss from operations (174,774) (268,766)
Other income (expense):    
Other income 14,000 0
Interest income 3 3
Interest expense on loan payable (2,466) 0
Non-cash interest expense on convertible notes (18,083) (18,283)
Accretion to redemption value on convertible notes 0 (1,446)
Total other income (expense), net (6,546) (19,726)
Loss before provision for income taxes (181,320) (288,492)
Provision for income taxes 0 0
Net loss $ (181,320) $ (288,492)
Basic loss per common share $ (0.03) $ (0.04)
Diluted loss per common share $ (0.03) $ (0.04)
Weighted average number of common shares outstanding - basic 7,236,447 7,236,447
Weighted average number of common shares outstanding - diluted 7,236,447 7,236,447